Analyst consensus rating
Encompass Health Analyst Rating: Strong Buy
EHC is rated Strong Buy by 12 analysts with a $148.17 target. As of 2026-08-25.
Direct answer
Encompass Health's consensus rating is Strong Buy.
12 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $148.17.
Forecast evidence checked August 25, 2026.
Get free Encompass Health email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $120.14
- Average price target
- $148.17
- High price target
- $155.00
- Low price target
- $140.00
- Low target gap
- +16.5%
- Target upside
- +23.3%
- High target gap
- +29%
- Target range width
- 12.5%
- Consensus rating
- Strong Buy
- Analysts
- 12
- Evidence date
- August 25, 2026
- Valid through
- September 1, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Encompass Health?
Encompass Health has a verified Strong Buy consensus. The same dataset has an average price target of $148.17.
How far are Encompass Health's low and high targets from the recorded price?
The low target implies +16.5%, while the high target implies +29%.
How many analysts are included in Encompass Health's consensus?
The verified consensus includes 12 analysts.
How is Encompass Health's target upside or downside calculated?
The average target of $148.17 is divided by the recorded price of $120.14, then one is subtracted to produce +23.3%. This does not guarantee a future return.
When was Encompass Health's analyst forecast verified?
The data was verified on 2026-08-25. The dataset is valid through 2026-09-01.